Policy – Page 5 – Talk Bio

Actionable Insights Powered by AI

U.S. Biotechs Reveal Tariff Exposure as Trade Inquiry Signals Imminent Pharmaceutical Tariffs

5 months ago talkbio0Tagged Evaluation, global supply chain, Impact food supplement, Import, Manufacturing, pharmaceutical ingredients, pharmaceutical tariffs, Policy, regulatory, reshoring, Sectioning technique, supply chain exposure, TNFRSF19 gene, United States

U.S. biotech, pharmaceutical tariffs, Section 232 investigation, supply chain exposure, trade policy, import costs, reshoring manufacturing, drug pricing, global supply chain, pharmaceutical ingredients, regulatory impact

Trump Announces Imminent Major Tariffs on Pharmaceuticals: Implications for Global Markets and U.S. Manufacturing

5 months ago talkbio0Tagged drug price, Impact food supplement, Pharma import taxes, pharmaceutical manufacturing, Pharmaceutical stocks, pharmaceutical tariffs, Policy, Relations, TNFRSF19 gene, Transplant Registry Unified Management Program, U.S.-China, United States

Trump pharmaceutical tariffs, U.S. pharmaceutical manufacturing, Pharma import taxes, Drug price impact, Trade policy 2025, U.S.-China trade relations, Pharmaceutical stocks

Drug pricing watchdog ICER offers ways to increase obesity drug access

5 months ago talkbio0Tagged Access, drug price, ICER, Obesity, Policy, Wegovy

ICER, Obesity, Access, Wegovy, Policy, drug price

FDAs policy, communications staff likely to be among agencys 3,500 staff cuts

6 months ago talkbio0Tagged CHARGE Syndrome, Communication, Policy, Staff, United States Food and Drug Administration

Policy, Communication, Staff, United States Food and Drug Administration, CHARGE Syndrome

Trump’s Looming Pharmaceutical Tariffs: Uncertainty and Potential Impact

6 months ago talkbio0Tagged Manufacturing, pharmaceutical tariffs, Policy, Prices, TNFRSF19 gene, Transplant Registry Unified Management Program

Trump, pharmaceutical tariffs, trade policy, drug prices, manufacturing, supply chain

CDC Vaccine Advisory Committee Meeting Postponed Following RFK Jr.’s Confirmation as HHS Secretary

7 months ago talkbio0Tagged ACIP, Centers for Disease Control and Prevention (U.S.), CHARGE Syndrome, HHS, Immunization, Policy, public health medicine (field), Recommendation, Robert F. Kennedy, Vaccines

ACIP, CDC, vaccine recommendations, Robert F. Kennedy Jr., HHS, postponement, public health, immunization policy

Trump Imposes New Tariffs on Canada, Mexico, and China; Medical Industry Seeks Exemptions

7 months ago talkbio0Tagged Canada, China, fentanyl crisis, illegal immigration, medical technology exemptions, Mexico, National Security, Policy, TNFRSF19 gene, Trump tariffs

Trump tariffs, Canada, Mexico, China, medical technology exemptions, trade policy, national security, fentanyl crisis, illegal immigration

Trump 2.0: RFK Confirmation Hearings and Ongoing Clinical Trials Amidst Administrative Changes

8 months ago talkbio0Tagged Clinical Trials, Confirmation, Hearings, NIH Mouse, Partnership, Policy, RFK gene, Transplant Registry Unified Management Program

Trump 2.0, RFK Confirmation Hearings, Clinical Trials, NIH Grant Reviews, US-India Partnership, Second Term Policies

Trump’s Re-Election: A Mixed Bag for Biopharma with M&A Upsides and Vaccine Concerns

9 months ago talkbio0Tagged Acquisitions, Administration occupational activities, Biopharma, Independence, Inflation, mergers, Policy, Transplant Registry Unified Management Program, United States Food and Drug Administration, Vaccines

Trump Administration, Biopharma, Mergers and Acquisitions, Vaccine Policy, Robert F. Kennedy Jr., FDA Independence, Inflation Reduction Act

Biopharma Industry Braces for Uncertainty Under Trump’s Second Term: Impact on Vaccines and M&A Deals

10 months ago talkbio0Tagged Biopharma Industry, Changing, FTC, Health Policy, M&A, Policy, Regulation, second, Trump 's, United States Federal Trade Commission, Vaccines

Trump’s second term, Biopharma industry, Vaccine regulation, Robert F. Kennedy Jr., M&A deals, FTC policy changes, Healthcare policy uncertainty